16534-24-0
16534-24-0
Chemical Structure
Cinnamoylglycine
- CAS No.: 16534-24-0
- Formula:C11H11NO3
- Molecular Weight:205.21
IUPAC Name: cinnamoylglycine
InChIKey: YAADMLWHGMUGQL-VOTSOKGWSA-N
SMILES: O=C(O)CNC(/C=C/C1=CC=CC=C1)=O
Biological Activity: Cinnamoylglycine is a human urinary metabolite and PPG analog. Cinnamoylglycine is a conjugate of cinnamic acid and glycine. Cinnamoylglycine is used as a urine marker. Cinnamoylglycine can be used in adipogenic differentiation studies[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cinnamoylglycine | 95.0% | Cinnamoylglycine is a human urinary metabolite and PPG analog. Cinnamoylglycine is a conjugate of cinnamic acid and glycine. Cinnamoylglycine is used as a urine marker. Cinnamoylglycine can be used in adipogenic differentiation studies. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cinnamoylglycine (Standard) | ≥98% | Cinnamoylglycine (Standard) is the analytical standard of Cinnamoylglycine. This product is intended for research and analytical applications. Cinnamoylglycine is a glycine conjugate of cinnamic acid and a urinary metabolite in human. Cinnamoylglycine is used as a potential urinary biomarker indicating intact or disrupted colonization resistance during and after antibiotic treatment. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Cinnamoylglycine-d2 | Cinnamoylglycine-d2 is the deuterium labeled Cinnamoylglycine. Cinnamoylglycine is a glycine conjugate of cinnamic acid and a urinary metabolite in human. Cinnamoylglycine is used as a potential urinary biomarker indicating intact or disrupted colonization resistance during and after antibiotic treatment. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Obrenovich ME, et al. Targeted Metabolomics Analysis Identifies Intestinal Microbiota-Derived Urinary Biomarkers of Colonization Resistance in Antibiotic-Treated Mice.Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00477-17. [Content Brief]
- [2]. Jung HR, et al. Gut bacteria-derived 3-phenylpropionylglycine mitigates adipocyte differentiation of 3T3-L1 cells by inhibiting adiponectin-PPAR pathway. Genes Genomics. 2023 Jan;45(1):71-81. [Content Brief]
